摘要
目前,乙型病毒性肝炎已经引起世界性的广泛关注,而我国又是世界上感染乙型肝炎病毒人数最多的国家,因此,乙型病毒性肝炎治疗药物备受瞩目。现用于治疗慢性乙型病毒性肝炎的药物主要有核苷类似物、干扰素和免疫调节剂3大类。该文对已经上市的乙型病毒性肝炎治疗药物的研究情况进行了简单介绍。
Contemporarily, hepatitis B has raised large amount of attention in global scale. Meanwhile, China is a country with the largest number of infected patients. Hence, the therapeutic drugs of hepatitis B become the focus of attention. So far, there are three types of them, including nucleoside drugs, interferon and immunomodulator. Some research status for therapeutic drugs of hepatitis B on the market is briefly introduced.
出处
《中国药业》
CAS
2010年第1期1-3,共3页
China Pharmaceuticals
